Etidronate is a medication that is licensed to treat heterotopic ossification and Paget's disease. This eMedTV segment discusses etidronate uses in more detail, describes how the drug works, and explains how and when to take the medicine.
The most common side effects of etidronate seen in clinical trials include bone pain, nausea, and diarrhea. This eMedTV article also lists side effects that were seen in postmarketing experience and explains which problems require medical attention.
Etidronate is used for the treatment of Paget's disease and heterotopic ossification. This page from the eMedTV Web site further explores specific etidronate uses and explains whether the medicine is used off-label for other conditions.
Etidronate dosing for the treatment of Paget's disease usually starts at 5 mg per kg (of weight) once daily. This eMedTV segment also lists dosing recommendations for heterotopic ossification caused by spinal cord injury or hip replacement surgery.
Foods and beverages can cause negative etidronate interactions. As this part of the eMedTV library explains, certain medicines can also cause drug interactions with etidronate, including warfarin, teriparatide, and calcium products.
You should not take etidronate if you have osteomalacia (weak bones caused by a vitamin D deficiency). This eMedTV Web page includes other precautions and warnings with etidronate and lists possible side effects that may occur with the drug.
| Referring Pages | Articles |
